EF Hutton initiated coverage on TC BioPharm (Holdings) PLC TCBP +20.4% + Free Alerts with a Buy rating. The price target for TC BioPharm (Holdings) is set to $5.00. The stock has a 52-week-high of $3.50 and a 52-week-low of $0.88. At the end of the last trading period, TC BioPharm (Holdings) closed at $1.20.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”